Merck Buys Verona Pharma in $10B Post-Keytruda Push
Deal adds blockbuster potential as Keytruda patent cliff nears
Merck announced Wednesday it will acquire UK-based Verona Pharma for approximately $10 billion, securing access to...
Novartis Gets Swiss Nod for First Malaria Drug for Babies
Coartem Baby to close treatment gap for Africa’s youngest patients
Novartis announced on Tuesday it has received regulatory approval in Switzerland for Coartem Baby, the...
Moderna Flu Vaccine Beats Competitor in Final Trial
Stronger immune response clears path for combo Covid-flu shot
Moderna announced Monday that its experimental mRNA-based flu vaccine outperformed an existing standard shot in a...
Nestlé to Eliminate Synthetic Food Colors by Mid-2026
U.S. food industry accelerates shift to cleaner labels amid new health regulations
Nestlé USA announced Wednesday that it will eliminate all synthetic food colors from...
FDA Launches Fast-Track Reviews for Key Medicines
New initiative cuts drug review time to as little as 30 days
The U.S. Food and Drug Administration (FDA) announced Tuesday a new fast-track initiative...
BioNTech Acquires CureVac for $1.25 Billion in Share Deal
Deal Overview
German biotech firm BioNTech has announced the acquisition of its rival CureVac for approximately $1.25 billion in BioNTech shares. This move aims to...